Already FDA-approved to treat major depression and migraines, TMS can now be marketed as a treatment for obsessive compulsive disorder Santa Barbara, Calif., September 21, 2018 – Transcranial Magnetic Stimulation (TMS) therapy is rapidly growing in popularity as a treatment [..]
Leading National TMS provider—more locations, more doctors, more experience, more success!
Mar 25
About 18 percent of people will experience depression in their lifetime, and about a third won’t get better with medication. But there’s a treatment in the Valley that may offer a glimmer of hope for those who can’t see a light at the end of the tunnel.
Insurance coverage is widely available
Insurance Coverage Information
Patient Self Assessment & Tools
TMS Information for Practitioners
APA Guidelines
TMS Success Stories
NEWS / RESEARCH
